Armc8 expression was elevated during atypia-to-carcinoma progression and associated with cancer development of breast carcinoma

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11337-11343

  Fan, Chuifeng ^a   Zhao, Yang ^a   Mao, Xiaoyun ^a   Miao, Yuan ^a   Lin, Xuyong ^a   Jiang, Guiyang ^a   Zhang, Xiupeng ^a   Han, Qiang ^a   Luan, Lan ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Armc8; Breast carcinoma; Dysplasia; Hyperplasia; IHC

Indexed keywords

ARMADILLO DOMAIN PROTEIN; ARMC8 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; BREAST; BREAST TUMOR; CANCER GRADING; CANCER STAGING; CARCINOMA IN SITU; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; FIBROADENOMA; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; HUMAN; HYPERPLASIA; LUNG CARCINOMA; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SECONDARY; WESTERN BLOTTING;

ADULT; AGED; ARMADILLO DOMAIN PROTEINS; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FIBROADENOMA; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84927796216     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2473-0     Document Type: Article

References (16)

1. Takeyuki S, Atsuhisa U, Nobuaki K, et al. Proteasome-dependent degradation of α-catenin is regulated by interaction with Armc8α. Biochem. 2008;411:581–91.
2. Nawrocki B, Polette M, Van Hengel J, et al. Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol. 1998;153(5):1521–30.
3. Sadot E, Conacci-Sorrell M, Zhurinsky J, et al. Regulation of S33/S37 phosphorylated β-Catenin in normal and transformed cells. J Cell Sci. 2002;115(13):2771–80.
4. Alan W, Clayton Y, Christopher R, et al. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis. 2008;25(6):621–8.
5. Somesh B, Suresh K. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun. 2009;384(1):6–11.
6. Liu Y, Wang Y, Zhang Y, et al. Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer. Lung Cancer. 2009;63(3):375–82.
7. Travis W, Muller-Hermelink H, Harris C. World Health Organization classification of tumors: pathology and genetics of tumors of the female reproduction system. Lyon: IARC Press; 2004.
8. Carlson R, Allred C, Anderson B, et al. NCCN guidelines for patients: breast cancer. 2010.
9. Fan C, Yu J, Liu Y, et al. Increased NDRG1 expression is associated with advanced T stages and poor vascularization in non-small cell lung cancer. Pathol Oncol Res. 2012;18(3):549–56.
10. Nobuaki K, Jun Y, Atsuhisa U, et al. RanBPM, muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8α and ARMC8β are components of the CTLH complex. Gene. 2007;396:236–47.
11. Koji T, Atsuhisa U, Takeyuki S, et al. Armadillo repeat containing 8α binds to HRS and promotes HRS interaction with ubiquitinated proteins. Open Biochem J. 2010;4:1–8.
12. Bai M, Agnantis N, Kamina S, et al. In vivo cell kinetics in breast carcinogenesis. Breast Cancer Res. 2011;3:276–83.
13. Arpino G, Laucirica R, Elledge R. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med. 2005;143:446–57.
14. Steinman S, Wang J, Bourne P, et al. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Ann Clin Lab Sci. 2007;37:127–34.
15. Liu T, Niu Y, Yu Y, et al. Increased gamma-tubulin expression and P16INK4A promoter methylation occur together in preinvasive lesions and carcinomas of the breast. Ann Oncol. 2009;20:441–8.
16. Raynaud C, Hernandez J, Llorca F, et al. DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. Am J Clin Oncol. 2010;33:341–5.